125 related articles for article (PubMed ID: 36752320)
1. Structure-based virtual screening of novel natural products as chalcone derivatives against SARS-CoV-2 M
El Aissouq A; Bouachrine M; Bouayyadi L; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023; 41(22):13235-13249. PubMed ID: 36752320
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
[TBL] [Abstract][Full Text] [Related]
3. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
4.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CL
Prasetyo WE; Purnomo H; Sadrini M; Wibowo FR; Firdaus M; Kusumaningsih T
J Biomol Struct Dyn; 2023 Jul; 41(10):4467-4484. PubMed ID: 35470785
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S
J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 M
Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
[TBL] [Abstract][Full Text] [Related]
8. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
Majumder R; Mandal M
J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
[TBL] [Abstract][Full Text] [Related]
9. Natural-like products as potential SARS-CoV-2 M
Ibrahim MAA; Abdeljawaad KAA; Abdelrahman AHM; Hegazy MF
J Biomol Struct Dyn; 2021 Sep; 39(15):5722-5734. PubMed ID: 32643529
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
11. 25 (S)-Hydroxycholesterol acts as a possible dual enzymatic inhibitor of SARS-CoV-2 M
Alzahrani FA; Alkarim SA; Hawsawi YM; Abdulaal WH; Albiheyri R; Kurdi B; Alguridi H; El-Magd MA
J Biomol Struct Dyn; 2023 Jul; 41(10):4744-4755. PubMed ID: 35510619
[TBL] [Abstract][Full Text] [Related]
12.
Xie S; Cao S; Wu J; Xie Z; Liu YT; Fu W; Zhao Q; Liu L; Yang L; Li J
J Biomol Struct Dyn; 2024 Jul; 42(10):5229-5237. PubMed ID: 37349935
[TBL] [Abstract][Full Text] [Related]
13. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
14. Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease.
Durgam L; Guruprasad L
J Biomol Struct Dyn; 2023 Jun; 41(9):3741-3751. PubMed ID: 35333147
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
Abdizadeh R; Hadizadeh F; Abdizadeh T
J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
[TBL] [Abstract][Full Text] [Related]
16. Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Murali M; Gowtham HG; Shilpa N; Krishnappa HKN; Ledesma AE; Jain AS; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Ortega-Castro J; Frau J; Flores-HolguĂn N; Amruthesh KN; Shivamallu C; Kollur SP; Glossman-Mitnik D
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500380
[TBL] [Abstract][Full Text] [Related]
17. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
18.
Kumar R; Kumar R; Tanwar P
J Biomol Struct Dyn; 2022 Oct; 40(16):7394-7407. PubMed ID: 33715592
[TBL] [Abstract][Full Text] [Related]
19.
Erdogan T
J Biomol Struct Dyn; 2023 Apr; 41(6):2448-2465. PubMed ID: 35088655
[TBL] [Abstract][Full Text] [Related]
20. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]